Latham & Watkins
Robbie McLaren
- Deals
- 3
- Latest
- Oct 2026
Firm
- Latham & Watkins Law firm · 2026 · 3 deals
Often works with
- Giovanni Sandicchi 2 deals together
- Lydia Torne 2 deals together
- Oscar Hayward 2 deals together
- Thomas Lane 2 deals together
- Gregory Slevin 2 deals together
- Elliot Brownlee 1 deal together
- Annie Grimes 1 deal together
- Luke Nauth 1 deal together
Deals
Columns
| Oct 2026 | Microbiogen | selling shareholders of Microbiogen | Novonesis | Acquisition | Legal adviser to Novonesis (acquirer) | Completed | – | Chemicals | Novonesis acquisition of Microbiogen |
| Aug 2026 | Numantec | – | Goldman Sachs Alternatives | Acquisition | Legal adviser to Goldman Sachs Alternatives (acquirer) | Announced | – | Medtech+1 | Goldman Sachs Alternatives acquisition of Numantec |
| May 2026 | Recordati S.p.A. | – | CVC GBL | Acquisition | Legal adviser to consortium led by CVC Fund IX and a Groupe Bruxelles Lambert vehicle (acquirer) | Announced | 17,587.3 | Pharma | CVC GBL acquisition of Recordati S.p.A. |
Deals where Robbie McLaren is named on the firm's deal team, by the firm or the press.